Recently, a new breakthrough in the treatment of osteoarthritis in China has been achieved with the application of a licensed device from Turkey—the Sterile Absorbable Hyaluronic Acid-Containing Intra Articular Gel Implant, namely, Supintro™—which was used for the first time in China at Boao Lecheng in Hainan. This development will provide innovative international treatment options to patients suffering from osteoarthritis.